AstraZeneca’s Asthma Injection Helps Lungs in Advanced TestsBy
Patients’ lung function improved four weeks after first shot
Benralizumab to enter crowded field led by Glaxo, Teva drugs
An AstraZeneca Plc injection helped boost lung function and relieve the symptoms of patients with severe asthma in two advanced clinical trials, paving the way for a regulatory submission later this year.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.